• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性黄体生成素血清水平对人绒毛膜促性腺激素注射日孕激素升高的影响。

Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.

机构信息

Center for Reproductive Medicine, Jean Verdier Hospital, University Paris XIII, Paris, France.

出版信息

Fertil Steril. 2011 Sep;96(3):600-4. doi: 10.1016/j.fertnstert.2011.06.061.

DOI:10.1016/j.fertnstert.2011.06.061
PMID:21880277
Abstract

OBJECTIVE

To assess the relationship between endogenous LH serum levels after GnRH analogue administration and serum P elevation on the day of hCG administration (P hCG).

DESIGN

Retrospective study.

SETTING

Reproductive medicine center in a university hospital.

PATIENT(S): A total of 708 patients undergoing a GnRH agonist or antagonist protocol for IVF intracytoplasmic sperm injection.

INTERVENTION(S): Controlled ovarian stimulation.

MAIN OUTCOME MEASURE(S): Serum P values according to GnRH analogue; correlation between serum LH measurements and P hCG values.

RESULT(S): Serum P hCG values were significantly lower following the GnRH antagonist than agonist protocol. A positive correlation between serum P hCG and LH area under the curve or day 6 LH values was found in the GnRH agonist group and between P hCG and LH hCG levels in both GnRH analogue regimens. With multivariate analysis, P hCG values were positively correlated with serum E(2) levels on hCG administration day and with the total FSH dose in both GnRH analogue-treated groups. Additionally, the correlation between serum P hCG and LH hCG values was positive in patients treated with the GnRH agonist protocol.

CONCLUSION(S): The lower serum P levels on hCG administration day following the GnRH antagonist protocol are mainly explained by lower granulosa cell steroidogenic activity. The correlation with serum LH hCG values was positive in the GnRH agonist-treated group.

摘要

目的

评估 GnRH 类似物给药后血清内源性 LH 水平与 hCG 给药日(P hCG)血清 P 升高之间的关系。

设计

回顾性研究。

地点

大学医院生殖医学中心。

患者

共 708 例接受 GnRH 激动剂或拮抗剂方案进行 IVF 胞浆内精子注射的患者。

干预措施

控制性卵巢刺激。

主要观察指标

根据 GnRH 类似物的血清 P 值;血清 LH 测量值与 P hCG 值之间的相关性。

结果

与 GnRH 激动剂方案相比, GnRH 拮抗剂方案后的血清 P hCG 值明显较低。在 GnRH 激动剂组中,血清 P hCG 与 LH 曲线下面积或第 6 天 LH 值呈正相关,在两种 GnRH 类似物方案中,P hCG 与 LH hCG 值之间存在正相关。多元分析显示,在 GnRH 类似物治疗组中,P hCG 值与 hCG 给药日血清 E2 水平和总 FSH 剂量呈正相关。此外,在 GnRH 激动剂治疗组中,血清 P hCG 与 LH hCG 值之间的相关性为正相关。

结论

GnRH 拮抗剂方案中 hCG 给药日血清 P 水平较低,主要是由于颗粒细胞甾体生成活性较低。在 GnRH 激动剂治疗组中,与血清 LH hCG 值呈正相关。

相似文献

1
Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.内源性黄体生成素血清水平对人绒毛膜促性腺激素注射日孕激素升高的影响。
Fertil Steril. 2011 Sep;96(3):600-4. doi: 10.1016/j.fertnstert.2011.06.061.
2
GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.促性腺激素释放激素激动剂(布舍瑞林)或人绒毛膜促性腺激素用于促性腺激素释放激素拮抗剂体外受精/卵胞浆内单精子注射周期的排卵诱导:一项前瞻性随机研究。
Hum Reprod. 2005 May;20(5):1213-20. doi: 10.1093/humrep/deh765. Epub 2005 Mar 10.
3
Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.补充重组人绒毛膜促性腺激素微剂量可导致使用促性腺激素释放激素激动剂或拮抗剂抑制垂体的情况下,使用重组卵泡刺激素进行卵巢刺激产生相似的结果。
Fertil Steril. 2010 Jun;94(1):167-72. doi: 10.1016/j.fertnstert.2009.02.075. Epub 2009 Apr 1.
4
Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.血清孕激素水平对不同卵巢反应患者体外受精结局的影响:超过 10000 个周期的分析。
Fertil Steril. 2012 Jun;97(6):1321-7.e1-4. doi: 10.1016/j.fertnstert.2012.03.014. Epub 2012 Apr 10.
5
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.当使用促性腺激素释放激素激动剂诱导排卵时,在取卵时给予 1500IU 人绒毛膜促性腺激素可挽救黄体期:一项前瞻性、随机、对照研究。
Fertil Steril. 2010 Feb;93(3):847-54. doi: 10.1016/j.fertnstert.2008.12.042. Epub 2009 Feb 6.
6
An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol.在使用长效促性腺激素释放激素激动剂方案治疗的卵巢储备功能正常的女性中,人绒毛膜促性腺激素给药当天血清孕酮与雌二醇比值升高对临床妊娠率没有负面影响。
Fertil Steril. 2009 Aug;92(2):508-14. doi: 10.1016/j.fertnstert.2008.06.036. Epub 2008 Aug 12.
7
Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy.每日使用促性腺激素释放激素拮抗剂预防体外受精/卵胞浆内单精子注射患者过早出现促黄体生成素峰的剂量探索性研究:促黄体生成素和孕酮对临床妊娠的最佳变化情况
Hum Reprod. 2005 Feb;20(2):359-67. doi: 10.1093/humrep/deh601. Epub 2004 Nov 26.
8
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.促性腺激素释放激素激动剂和人绒毛膜促性腺激素双重触发可显著提高 GnRH 拮抗剂周期中正常反应者的活产率。
Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.
9
Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.微剂量促性腺激素释放激素激动剂激发方案与多剂量促性腺激素释放激素拮抗剂方案用于接受卵胞浆内单精子注射-胚胎移植周期的低反应者的比较
Fertil Steril. 2009 Jun;91(6):2437-44. doi: 10.1016/j.fertnstert.2008.03.057. Epub 2008 Jun 13.
10
Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.促性腺激素释放激素激动剂周期中 hCG 日血清孕酮和雌二醇浓度对妊娠结局的影响。
Reprod Biomed Online. 2012 May;24(5):511-20. doi: 10.1016/j.rbmo.2012.02.003. Epub 2012 Feb 14.

引用本文的文献

1
Luteinizing hormone profiles during ovarian stimulation in assisted reproductive treatment.辅助生殖治疗中卵巢刺激期间的促黄体生成素谱。
Front Endocrinol (Lausanne). 2024 Dec 4;15:1481546. doi: 10.3389/fendo.2024.1481546. eCollection 2024.
2
Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus.控制性卵巢刺激中促黄体生成素补充治疗:伊朗德尔菲共识
Front Reprod Health. 2024 May 9;6:1397446. doi: 10.3389/frph.2024.1397446. eCollection 2024.
3
Increasing dominant follicular proportion negatively associated with good clinical outcomes in normal ovarian responders using the depot GnRH agonist protocol: a large-sample retrospective analysis.
在使用长效 GnRH 激动剂方案的正常卵巢反应者中,优势卵泡比例增加与良好的临床结局呈负相关:一项大样本回顾性分析。
J Ovarian Res. 2022 Apr 13;15(1):44. doi: 10.1186/s13048-022-00973-7.
4
Correlation of progesterone levels on the day of oocyte retrieval with basal hormonal status and the outcome of ART.取卵日孕激素水平与基础激素状态及 ART 结局的相关性。
Sci Rep. 2020 Dec 18;10(1):22291. doi: 10.1038/s41598-020-79347-2.
5
Revisiting debates of premature luteinization and its effect on assisted reproductive technology outcome.重新探讨黄体化过早及其对辅助生殖技术结局的影响的争论。
J Assist Reprod Genet. 2019 Nov;36(11):2195-2206. doi: 10.1007/s10815-019-01598-4. Epub 2019 Oct 25.
6
The curious case of premature luteinization.早发性黄体化的奇特案例。
J Assist Reprod Genet. 2018 Oct;35(10):1723-1740. doi: 10.1007/s10815-018-1264-8. Epub 2018 Jul 26.
7
Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.比较不同刺激方案行 IVF 患者的卵泡液 Amphiregulin 和 EGF 浓度。
Endocrine. 2012 Dec;42(3):708-16. doi: 10.1007/s12020-012-9706-z. Epub 2012 Jun 8.